InsiderChief Legal Officer

Christine Ring Insider Trading Activity

Every SEC Form 4 transaction reported by Christine Ring, sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Christine Ring buying or selling?

Christine Ring reported 0 open-market buys ($0) and 62 sells ($6.1M) across 62 Form 4 filings at 1 company — a net selling position of $6.1M.

Source: SEC EDGAR Form 4

What stands out

  • All 62 of Christine Ring's Form 4 filings are for one company, Nurix Therapeutics, Inc. (NRIX).
  • The most recent Form 4 was accepted on Oct 2, 2026 (16 days ago).
  • In the last 12 months: no open-market purchases and 18 sales ($3.4M).
  • The largest open-market sale in the last 12 months was $641.7K of Nurix Therapeutics, Inc. (NRIX) on Nov 24, 2025. SEC ↗

Key Statistics (as of Oct 2, 2026)

Total Form 4 filings
62
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (62)
$6.1M

Insider sentiment

Net selling

Net insider flow of $6.1M in net selling, filed between Feb 22, 2021 – Oct 2, 2026.

Companies Christine Ring files for

#CompanyForm 4 filings
1NRIXNurix Therapeutics, Inc.62

Recent Christine Ring transactions

DateTickerRoleTypeSharesValueFiling
Oct 2, 2026NRIXChief Legal OfficerSale5.8K$134.1KSEC ↗
Sep 2, 2026NRIXChief Legal OfficerSale5.8K$149.1KSEC ↗
Aug 3, 2026NRIXChief Legal OfficerSale16.6K$382.4KSEC ↗
Jul 30, 2026NRIXChief Legal OfficerSale3.8K$90.0KSEC ↗
Jul 2, 2026NRIXChief Legal OfficerSale11.0K$259.4KSEC ↗
Jun 25, 2026NRIXChief Legal OfficerSale28.9K$580.5KSEC ↗
Jun 2, 2026NRIXChief Legal OfficerSale8.1K$135.3KSEC ↗
May 4, 2026NRIXChief Legal OfficerSale8.1K$138.2KSEC ↗
May 1, 2026NRIXChief Legal OfficerSale5.4K$90.4KSEC ↗
Apr 30, 2026NRIXChief Legal OfficerSale3.2K$53.5KSEC ↗
Apr 2, 2026NRIXChief Legal OfficerSale8.1K$124.1KSEC ↗
Mar 3, 2026NRIXChief Legal OfficerSale8.1K$125.8KSEC ↗
Feb 10, 2026NRIXChief Legal OfficerSale14.3K$237.6KSEC ↗
Jan 31, 2026NRIXChief Legal OfficerSale4.4K$73.4KSEC ↗
Jan 21, 2026NRIXChief Legal OfficerSale3.8K$69.3KSEC ↗
Dec 18, 2025NRIXChief Legal OfficerSale3.8K$67.3KSEC ↗
Nov 24, 2025NRIXChief Legal OfficerSale37.6K$641.7KSEC ↗
Oct 30, 2025NRIXChief Legal OfficerSale3.6K$46.6KSEC ↗
Jul 30, 2025NRIXChief Legal OfficerSale3.8K$46.1KSEC ↗
Apr 30, 2025NRIXChief Legal OfficerSale2.9K$33.3KSEC ↗
Feb 4, 2025NRIXChief Legal OfficerSale5.8K$114.9KSEC ↗
Jan 31, 2025NRIXChief Legal OfficerSale3.2K$63.9KSEC ↗
Jan 2, 2025NRIXChief Legal OfficerSale5.8K$112.3KSEC ↗
Dec 2, 2024NRIXChief Legal OfficerSale5.8K$125.2KSEC ↗
Nov 4, 2024NRIXChief Legal OfficerSale3.3K$82.3KSEC ↗

Showing the 25 most recent filings of 62. Screen every filing.

Christine Ring insider trading FAQ

Is Christine Ring buying or selling?

Across 62 SEC Form 4 filings, Christine Ring reported 0 open-market purchases totaling $0 and 62 sales totaling $6.1M — a net selling position of $6.1M.

Which companies does Christine Ring file Form 4s for?

Christine Ring has reported insider transactions at 1 company, most often Nurix Therapeutics, Inc. (NRIX).

How far back does Christine Ring's filing history go?

Trabud holds Christine Ring's SEC Form 4 filings from Feb 22, 2021 – Oct 2, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Christine Ring's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Christine Ring and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener